These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37159349)

  • 21. Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis.
    Srisurapanont M; Likhitsathian S; Suttajit S; Maneeton N; Maneeton B; Oon-Arom A; Suradom C
    Drug Alcohol Depend; 2021 Feb; 219():108467. PubMed ID: 33385693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.
    Arango C; Ng-Mak D; Finn E; Byrne A; Loebel A
    Eur Child Adolesc Psychiatry; 2020 Sep; 29(9):1195-1205. PubMed ID: 31758359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
    Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis.
    Rogdaki M; McCutcheon RA; D'Ambrosio E; Mancini V; Watson CJ; Fanshawe JB; Carr R; Telesia L; Martini MG; Philip A; Gilbert BJ; Salazar-de-Pablo G; Kyriakopoulos M; Siskind D; Correll CU; Cipriani A; Efthimiou O; Howes OD; Pillinger T
    Lancet Child Adolesc Health; 2024 Jul; 8(7):510-521. PubMed ID: 38897716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia.
    Dong S; Schneider-Thoma J; Bighelli I; Siafis S; Wang D; Burschinski A; Schestag K; Samara M; Leucht S
    Eur Arch Psychiatry Clin Neurosci; 2024 Jun; 274(4):917-928. PubMed ID: 37526675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.
    Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Kissling W; Davis JM; Leucht S
    Schizophr Bull; 2012 Jan; 38(1):167-77. PubMed ID: 20513652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
    Leucht S; Crippa A; Siafis S; Patel MX; Orsini N; Davis JM
    Am J Psychiatry; 2020 Apr; 177(4):342-353. PubMed ID: 31838873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan.
    Kishi T; Ikuta T; Sakuma K; Okuya M; Iwata N
    J Psychiatr Res; 2021 Jun; 138():444-452. PubMed ID: 33964682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
    Temmingh HS; Williams T; Siegfried N; Stein DJ
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zotepine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Jan; (1):CD006628. PubMed ID: 20091601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antipsychotic Treatment of the Adult Patient in the Acute Phase of Schizophrenia].
    Bohórquez Peñaranda A; Gómez Restrepo C; García Valencia J; Jaramillo González LE; de la Hoz AM; Arenas Á; Tamayo Martínez N
    Rev Colomb Psiquiatr; 2014; 44 Suppl 1():13-28. PubMed ID: 26576459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zotepine versus other atypical antipsychotics for schizophrenia.
    Subramanian S; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Kissling W; Leucht S; Komossa K
    Cochrane Database Syst Rev; 2010 Oct; (10):CD006628. PubMed ID: 20927748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
    Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
    Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants.
    Ostuzzi G; Bertolini F; Tedeschi F; Vita G; Brambilla P; Del Fabro L; Gastaldon C; Papola D; Purgato M; Nosari G; Del Giovane C; Correll CU; Barbui C
    World Psychiatry; 2022 Jun; 21(2):295-307. PubMed ID: 35524620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
    Soares-Weiser K; Béchard-Evans L; Lawson AH; Davis J; Ascher-Svanum H
    Eur Neuropsychopharmacol; 2013 Feb; 23(2):118-25. PubMed ID: 22633617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders: A Systematic Review and Network Meta-Analysis.
    Yee CS; Bahji A; Lolich M; Vázquez GH; Baldessarini RJ
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):198-208. PubMed ID: 35020712
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.